Share

Endocrine Society’s 2023 Advocacy Accomplishments

The Endocrine Society is advocating for you. In 2023 we achieved several important advocacy accomplishments, including:  All these accomplishments were achieved because our members participated in our advocacy activities, online campaigns, Hill Days, and meetings with policymakers. Below are some examples of our advocacy victories.  Advocacy to Lower the Cost of Insulin – The Endocrine Society...
Share

Endocrine Society’s Advocacy Initiatives – December 2023

Government Shutdown Averted for Second Time as Society Advocates to Fund Health, Research Programs  With the clock running out on a federal government shutdown that was to begin midnight November 17, Congress passed a short-term bill to keep the government open. The bill will fund most health programs, including the National Institutes of Health (NIH),...
Share

Endocrine Society Continues to Advocate for Insulin Affordability

The Endocrine Society continues to advocate for insulin affordability. Although new legislation to make insulin more affordable has been stalled in Congress, the Centers for Medicare and Medicaid Services (CMS) continues to advance a program to implement drug price negotiations to lower the cost of certain prescription drugs, including several diabetes medications. CMS recently hosted...
Share

Four Diabetes Drugs Included in Medicare Price Negotiation List

In September, the federal government unveiled a list of the first 10 drugs that will undergo price negotiations between Medicare and pharmaceutical companies. Notably, four of these drugs are diabetes medications. New prices for these medicines will be announced in September 2024 and new prices will take effect on January 1, 2026, unless pharmaceutical companies...
Share

Society Hosts Congressional Briefing on Anti-Obesity Medications as TROA Moves Forward in the House

The Endocrine Society hosted a congressional briefing in September to educate members of Congress and congressional staff on anti-obesity medications. The briefing featured two Endocrine Society members who are experts in obesity medicine. Jonathan Purnell, MD, professor of medicine at Oregon Health & Science University, provided attendees with an opportunity to learn more about these...
Share

Endocrine Society Supports Proposed MPFS Payment Increase for Endocrinology

The Endocrine Society responded to the Centers for Medicare and Medicaid Services (CMS) proposed Medicare Physician Fee Schedule (MPFS) by advocating to maintain increase for endocrinology. This annual rule updates payment policies and payment rates for Part B services furnished under the MPFS. Every year, CMS requests public comment on its proposed changes. We are pleased that the proposed...
Share

Federal Government Spending Battles Continue

While Congress avoided the U.S. defaulting on its loans and an international financial disaster by reaching a deal to suspend the country’s the debt limit, the deal included budget caps that will dramatically affect federal spending for the next two years. This agreement on budget caps now extends to congressional decisions on the annual appropriations...